Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
 

This article is part of the supplement: Frontiers of Retrovirology: Complex retroviruses, retroelements and their hosts .

Open AccessPoster presentation

Human miRNAs: an antiviral defense mechanism

Kartik Soni1, Jasmine K Ahluwalia1, Sohrab Zafar Khan2, Beena Pillai1, Debashis Mitra1 and Samir K Brahmachari1

Instituite of Genomics and Integrative Biology, New Delhi, India

National Centre For Cell Science, Pune, India

corresponding author email

from Frontiers of Retrovirology: Complex retroviruses, retroelements and their hosts
Montpellier, France. 21-23 September 2009

Retrovirology 2009, 6(Suppl 2):P83doi:10.1186/1742-4690-6-S2-P83

The electronic version of this abstract is the complete one and can be found online at: http://www.retrovirology.com/content/6/S2/P83

Published: 24 September 2009

© 2009 Soni et al; licensee BioMed Central Ltd.

Background

miRNAs are short 21-24 nt RNAs that mediate post transcriptional repression of target genes. Various reports have shown that miRNAs are capable of repressing the gene expression levels of different viruses, leading to the suggestion that miRNAs are key mediators of host-virus interaction [1]. HIV-1 is a retrovirus known to cause AIDS, one of the major diseases in humans. The nef gene of the HIV-1 has been shown to be important for virus repression of CD4+ cells and virus progression. It has also been shown earlier that patients infected with nef deleted HIV-1 do not progress from infected to diseased state for longer periods of time, resulting in the Long Term Non-Progressor phenotype [2].

Materials and methods

We computationally predicted five endogenously expressed human miRNAs to target the nef gene of HIV-1 retrovirus. On applying other stringency parameters we could focus on two of the five miRNAs viz. hsa-mir-29a and hsa-mir-29b as they were predicted to target the nef gene, at sites highly conserved amongst other clades of HIV-1 [3].

We then created reporter carrying the nef gene inserted downstream of a luciferase reporter. miRNA expression vectors were also made which would express the pri-miRNA when processed and thereby lead to high levels of the miRNA inside the cells. We then identified various cell lines for validating nef as a target for hsa-mir-29a and hsa-mir-29b.

Results and discussion

Gene reporter assays and ectopic over-expression of miRNAs conclusively showed that human cellular miRNAs hsa-mir-29a and hsa-mir-29b could bring down the nef protein levels and also affect viral replication [4]. These results would provide a better understanding of the mechanisms that could regulate the viral gene expression and human cellular antiviral defense mechanisms whereby miRNAs could serve as potential therapeutics to treat various viral diseases.

References

  1. Scaria V, Hariharan M, Maiti S, Pillai B, Brahmachari SK: Host-virus interaction: a new role for microRNAs.

    Retrovirology 2006, 3:68. PubMed Abstract | BioMed Central Full Text | PubMed Central Full Text OpenURL

  2. Deacon NJ, Tsykin A, Solomon A, Smith K, Ludford-Menting M, Hooker DJ, McPhee DA, Greenway AL, Ellett A, Chatfield C, et al.: Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients.

    Science 1995, 270:988-991. PubMed Abstract | Publisher Full Text OpenURL

  3. Hariharan M, Scaria V, Pillai B, Brahmachari SK: Targets for human encoded microRNAs in HIV genes.

    Biochem Biophys Res Commun 2005, 337:1214-1218. PubMed Abstract | Publisher Full Text OpenURL

  4. Ahluwalia JK, Khan SZ, Soni K, Rawat P, Gupta A, Hariharan M, Scaria V, Lalwani M, Pillai B, Mitra D, Brahmachari SK: Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication.

    Retrovirology 2008, 5:117. PubMed Abstract | BioMed Central Full Text | PubMed Central Full Text OpenURL

Have something to say? Post a comment on this article!


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.